A police officer manages people who came to receive a dose of a coronavirus disease vaccine outside a vaccination centre in Ahmedabad, India, June 30, 2021. REUTERS/Amit Davesaid on Thursday it has applied to the country's drug regulator for emergency use approval of its COVID-19 vaccine, which showed a 66.6% efficacy against positive cases in an interim analysis.
Coronavirus cases in India have dropped from a devastating peak in April and May, however, experts warned of a third wave and reiterated that widespread vaccination remains one of the best defences against the pandemic.the vaccine, which is a three-course regimen, showed safety and efficacy in a late-stage trial with more than 28,000 volunteers across the country, including about 1,000 subjects in the 12-18-year age group.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
India's Cipla gets approval to import Moderna's COVID-19 vaccine - CNBC-TV18India's Cipla Ltd (CIPL.NS) has received approval from the country's drugs regulator to import the COVID-19 vaccine developed by Moderna Inc (MRNA.O) for restricted emergency use, CNBC-TV18 reported on Tuesday, citing sources.
Source: Reuters - 🏆 2. / 97 Read more »
How to Stay Safe During This Week's Heat WavePlus, what to know about the COVID-19 vaccine and heat stroke.
Source: Allure_magazine - 🏆 473. / 51 Read more »
Russia's Sputnik V vaccine less effective against Delta variant -TASSRussia's Sputnik V vaccine against COVID-19 has been shown to be less effective against the highly contagious Delta variant, TASS news agency reported on Tuesday, citing the vaccine's developers. Vaccine needs another vaccine for the boost it seams It seems AstraZeneca is the way to go, please verify the rumours abt Sinovac miskalakhbar
Source: Reuters - 🏆 2. / 97 Read more »
Moderna says its COVID-19 vaccine should work against the Delta variantBusiness Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know. *should pretty much convincing, thx. good
Source: BusinessInsider - 🏆 729. / 51 Read more »
Brazil to suspend Indian COVID-19 vaccine deal as graft allegations probedBrazil will suspend a $324 million Indian COVID-19 vaccine contract that has mired President Jair Bolsonaro in accusations of irregularities, the health minister said on Tuesday, following the guidance of the federal comptroller, the CGU.
Source: Reuters - 🏆 2. / 97 Read more »
CureVac COVID-19 vaccine records only 48% efficacy in final trial readoutCureVac (5CV.DE) said its COVID-19 vaccine was 48% effective in the final analysis of its pivotal mass trial, only marginally better than the 47% reported after an initial read-out two weeks ago.
Source: Reuters - 🏆 2. / 97 Read more »